285 related articles for article (PubMed ID: 19178897)
1. Stage migration with sentinel node biopsy in breast cancer.
Layeequr Rahman R; Siegel E; Boneti C; Ingram M; Kepple J; Henry-Tillman RS; Klimberg VS
Am J Surg; 2009 Apr; 197(4):491-6. PubMed ID: 19178897
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma.
Flynn LW; Park J; Patil SM; Cody HS; Port ER
J Am Coll Surg; 2008 Apr; 206(4):616-21. PubMed ID: 18387465
[TBL] [Abstract][Full Text] [Related]
3. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.
Fan YG; Tan YY; Wu CT; Treseler P; Lu Y; Chan CW; Hwang S; Ewing C; Esserman L; Morita E; Leong SP
Ann Surg Oncol; 2005 Sep; 12(9):705-11. PubMed ID: 16079953
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.
Rivers AK; Griffith KA; Hunt KK; Degnim AC; Sabel MS; Diehl KM; Cimmino VM; Chang AE; Lucas PC; Newman LA
Ann Surg Oncol; 2006 Jan; 13(1):36-44. PubMed ID: 16378156
[TBL] [Abstract][Full Text] [Related]
7. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
8. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
9. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node.
Wada N; Imoto S; Yamauchi C; Hasebe T; Ochiai A
Eur J Surg Oncol; 2006 Feb; 32(1):29-33. PubMed ID: 16269227
[TBL] [Abstract][Full Text] [Related]
10. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D;
Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
13. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
14. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy.
McLaughlin SA; Ochoa-Frongia LM; Patil SM; Cody HS; Sclafani LM
J Am Coll Surg; 2008 Jan; 206(1):76-82. PubMed ID: 18155571
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of false-negative sentinel lymph nodes in breast cancer.
Zavagno G; Del Bianco P; Koussis H; Artioli G; Carraro P; De Salvo GL; Mencarelli R; Belardinelli V; Marconato G; Nitti D
Eur J Surg Oncol; 2008 Jun; 34(6):620-5. PubMed ID: 17764888
[TBL] [Abstract][Full Text] [Related]
17. Is breast cancer sentinel lymph node mapping valuable for patients in their seventies and beyond?
McMahon LE; Gray RJ; Pockaj BA
Am J Surg; 2005 Sep; 190(3):366-70. PubMed ID: 16105520
[TBL] [Abstract][Full Text] [Related]
18. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.
Noguchi M
Eur J Surg Oncol; 2008 Feb; 34(2):129-34. PubMed ID: 17498911
[TBL] [Abstract][Full Text] [Related]
19. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
20. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients.
Zavagno G; Carcoforo P; Franchini Z; Renier M; Barutta L; De Salvo GL; Maravegias K; Capitanio G; Nitti D; Lise M
Eur J Surg Oncol; 2005 Sep; 31(7):715-20. PubMed ID: 16005176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
